DNAprint Genomics (DNAG)

[easymedicine]

team.............................

Wanna see how those financial deals work out into the math of your investment? These are old ones. Imagine what a new share release of 1.5 billion shares will do! .0001 is coming.

Basic net loss per share is computed by dividing the net loss available to
common stockholders by the weighted average number of common shares outstanding
during the period. Diluted net loss per share is computed by dividing the net
loss for the period by the weighted average number of common and common
equivalent shares outstanding during the period. Common equivalent shares
outstanding as of December 31, 2004 and 2003, which consist of employee stock
options, warrants, convertible debenture as well as the issuance of common stock
under compensation agreements, have been excluded from diluted net loss per
common share calculations because they are anti-dilutive. Accordingly, basic and
diluted net loss per share is identical as of December 31, 2004 and 2003 and for
the period December 10, 1998 to December 31, 2004. The following table
summarizes our common stock equivalents outstanding at December 31, 2004 which
may dilute future earning per share.

Convertible notes ** 338,723,034
Convertible preferred stock ** 44,943,820
Warrants and options 26,650,308
--------------
410,217,162
==============

**The amount of shares the convertible notes and convertible preferred
stock was estimated using the conversion price at December 31, 2004.
The conversion price varies based upon the price of our common stock

http://xml.10kwizard.com/filing_raw.php?repo=tenk&ipage=3370094